Impact of infectious complications on gastric cancer recurrence. 2015

Tsutomu Hayashi, and Takaki Yoshikawa, and Toru Aoyama, and Shinichi Hasegawa, and Takanobu Yamada, and Kazuhito Tsuchida, and Hirohito Fujikawa, and Tsutomu Sato, and Takashi Ogata, and Haruhiko Cho, and Takashi Oshima, and Yasushi Rino, and Munetaka Masuda
Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, 241-8515, Japan.

BACKGROUND Postoperative infectious complications increase disease recurrence in colorectal cancer patients. We herein investigated the impact of infectious complications on gastric cancer recurrence after curative surgery. METHODS In total, 502 patients who underwent R0 resection for gastric cancer were reviewed. Patients were classified into those with infectious complications (IC group) and those without infectious complications (NO group). The risk factors for recurrence-free survival (RFS) were identified. RESULTS Infectious complications, which occurred in 52 patients (10.4%), included pneumonia, ileus with a systemic inflammatory reaction, anastomotic leakage, and intraperitoneal abscess. The overall 5-year RFS rate was 83% in the NO group and 58% in the IC group (p = 0.000). Multivariate analysis demonstrated that age, ASA score, stage, and infectious complications were significant predictors of RFS. CONCLUSIONS Infectious complications were a risk factor for gastric cancer recurrence. To avoid causing infectious complications, the surgical procedure, surgical strategy, and perioperative care should be carefully planned.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010534 Peritoneal Neoplasms Tumors or cancer of the PERITONEUM. Peritoneal Carcinomatosis,Peritoneal Surface Malignancy,Carcinomatosis, Peritoneal,Malignancy, Peritoneal Surface,Neoplasm, Peritoneal,Peritoneal Carcinomatoses,Peritoneal Neoplasm,Peritoneal Surface Malignancies,Surface Malignancy, Peritoneal
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses

Related Publications

Tsutomu Hayashi, and Takaki Yoshikawa, and Toru Aoyama, and Shinichi Hasegawa, and Takanobu Yamada, and Kazuhito Tsuchida, and Hirohito Fujikawa, and Tsutomu Sato, and Takashi Ogata, and Haruhiko Cho, and Takashi Oshima, and Yasushi Rino, and Munetaka Masuda
September 2022, American journal of surgery,
Tsutomu Hayashi, and Takaki Yoshikawa, and Toru Aoyama, and Shinichi Hasegawa, and Takanobu Yamada, and Kazuhito Tsuchida, and Hirohito Fujikawa, and Tsutomu Sato, and Takashi Ogata, and Haruhiko Cho, and Takashi Oshima, and Yasushi Rino, and Munetaka Masuda
January 2009, Hepato-gastroenterology,
Tsutomu Hayashi, and Takaki Yoshikawa, and Toru Aoyama, and Shinichi Hasegawa, and Takanobu Yamada, and Kazuhito Tsuchida, and Hirohito Fujikawa, and Tsutomu Sato, and Takashi Ogata, and Haruhiko Cho, and Takashi Oshima, and Yasushi Rino, and Munetaka Masuda
July 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Tsutomu Hayashi, and Takaki Yoshikawa, and Toru Aoyama, and Shinichi Hasegawa, and Takanobu Yamada, and Kazuhito Tsuchida, and Hirohito Fujikawa, and Tsutomu Sato, and Takashi Ogata, and Haruhiko Cho, and Takashi Oshima, and Yasushi Rino, and Munetaka Masuda
January 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Tsutomu Hayashi, and Takaki Yoshikawa, and Toru Aoyama, and Shinichi Hasegawa, and Takanobu Yamada, and Kazuhito Tsuchida, and Hirohito Fujikawa, and Tsutomu Sato, and Takashi Ogata, and Haruhiko Cho, and Takashi Oshima, and Yasushi Rino, and Munetaka Masuda
March 2021, Japanese journal of clinical oncology,
Tsutomu Hayashi, and Takaki Yoshikawa, and Toru Aoyama, and Shinichi Hasegawa, and Takanobu Yamada, and Kazuhito Tsuchida, and Hirohito Fujikawa, and Tsutomu Sato, and Takashi Ogata, and Haruhiko Cho, and Takashi Oshima, and Yasushi Rino, and Munetaka Masuda
March 2012, Surgical endoscopy,
Tsutomu Hayashi, and Takaki Yoshikawa, and Toru Aoyama, and Shinichi Hasegawa, and Takanobu Yamada, and Kazuhito Tsuchida, and Hirohito Fujikawa, and Tsutomu Sato, and Takashi Ogata, and Haruhiko Cho, and Takashi Oshima, and Yasushi Rino, and Munetaka Masuda
April 2015, Anticancer research,
Tsutomu Hayashi, and Takaki Yoshikawa, and Toru Aoyama, and Shinichi Hasegawa, and Takanobu Yamada, and Kazuhito Tsuchida, and Hirohito Fujikawa, and Tsutomu Sato, and Takashi Ogata, and Haruhiko Cho, and Takashi Oshima, and Yasushi Rino, and Munetaka Masuda
June 2020, The Annals of thoracic surgery,
Tsutomu Hayashi, and Takaki Yoshikawa, and Toru Aoyama, and Shinichi Hasegawa, and Takanobu Yamada, and Kazuhito Tsuchida, and Hirohito Fujikawa, and Tsutomu Sato, and Takashi Ogata, and Haruhiko Cho, and Takashi Oshima, and Yasushi Rino, and Munetaka Masuda
April 2017, Annals of surgical oncology,
Tsutomu Hayashi, and Takaki Yoshikawa, and Toru Aoyama, and Shinichi Hasegawa, and Takanobu Yamada, and Kazuhito Tsuchida, and Hirohito Fujikawa, and Tsutomu Sato, and Takashi Ogata, and Haruhiko Cho, and Takashi Oshima, and Yasushi Rino, and Munetaka Masuda
May 2022, Anticancer research,
Copied contents to your clipboard!